1. Home >
  2. M&A >
  3. Divestiture >
  4. Ireland >
  5. Sublimity Therapeutics Acquires Freund Pharmatec

M&A Deal Summary

Sublimity Therapeutics Acquires Freund Pharmatec

On February 4, 2016, Sublimity Therapeutics acquired life science company Freund Pharmatec from Freund

Acquisition Highlights
  • This is Sublimity Therapeutics’ 1st transaction in the Life Science sector.
  • This is Sublimity Therapeutics’ 1st transaction in Ireland.

M&A Deal Summary
Date 2016-02-04
Target Freund Pharmatec
Sector Life Science
Buyer(s) Sublimity Therapeutics
Sellers(s) Freund
Deal Type Divestiture

Target

Freund Pharmatec

Offaly, Ireland
Freund Pharmatec Ltd. is a specialty bio-pharmaceutical company.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sublimity Therapeutics

Dublin, Ireland
Category Company
Founded 2003
Sector Life Science
DESCRIPTION

Sublimity Therapeutics is a specialty pharmaceutical company developing innovative therapeutics for gastrointestinal and immunological diseases. Sublimity Therapeutics was founded in 2003 and is based in Dublin, Ireland.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Ireland M&A 1 of 1
Year: 2016 M&A 1 of 1

Seller(S) 1

SELLER

Freund

Tokyo, Japan
Category Company
Founded 1964
Sector Machinery
Employees427
Revenue 23.4B JPY (2025)
DESCRIPTION

Freund is a manufacturer of machinery for the pharmaceutical and food industry. Freund was founded in 1964 and is based in Tokyo, Japan.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Ireland M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal